Fertility and Sterility
Volume 94, Issue 1 , Pages 350.e8-350.e11, June 2010

An ongoing pregnancy from two waves of follicles developing during a long follicular phase of the same cycle

  • Yaakov Bentov, M.D., M.Sc.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
    • The Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
  • ,
  • Navid Esfandiari, D.V.M., Ph.D., H.C.L.D.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
    • The Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
  • ,
  • Asli Gokturk, M.Sc.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
  • ,
  • Eliezer Burstein, M.D.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
    • The Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
  • ,
  • Ofer Fainaru, M.D., Ph.D.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
    • The Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
  • ,
  • Robert F. Casper, M.D., F.R.C.S.C.

      Affiliations

    • Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada
    • The Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada
    • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Robert F. Casper, M.D., 150 Bloor Street W, Suite 210, Toronto, Ontario, Canada, M5S 2X9 (FAX: 416-972-0036).

Received 15 November 2009; received in revised form 9 December 2009; accepted 10 December 2009. published online 05 February 2010.

Objective

To report an ongoing pregnancy after in vitro fertilization (IVF) with ovarian stimulation using a gonadotropin-releasing hormone (GnRH) antagonist that resulted in two waves of follicular growth.

Design

Case report.

Setting

University of Toronto affiliated infertility clinic.

Patient(s)

A 33-year-old woman with a 3-year history of secondary infertility.

Intervention(s)

In vitro fertilization and embryo transfer.

Main Outcome Measure(s)

Ongoing pregnancy.

Result(s)

This patient successfully conceived after the GnRH antagonist-induced demise of the first cohort of follicles and the emergence of a second wave of follicles followed by oocyte retrieval on cycle day 30 and fresh embryo transfer.

Conclusion(s)

This case report is consistent with previous observations of multiple waves of follicle recruitment and growth per cycle. The window of implantation may not be adversely affected by prolonged or even variable estrogen exposure in the follicular phase of the cycle.

Key Words: In vitro fertilization, ovarian stimulation, follicular growth

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Y.B. has nothing to disclose. N.E. has nothing to disclose. A.G. has nothing to disclose. E.B. has nothing to disclose. O.F. has nothing to disclose. R.F.C. is on the scientific advisory boards for Abbott, Ferring, Insception Biosciences, Molecular Biometrics, Schering-Plough, and Wyeth; and has licensing agreements for patents with Barr Pharmaceuticals, Ortho-McNeil, EMD Serono, and Ferring; and owns stock in Insception Biosciences and Zircadium Inc.

PII: S0015-0282(09)04219-8

doi:10.1016/j.fertnstert.2009.12.033

Fertility and Sterility
Volume 94, Issue 1 , Pages 350.e8-350.e11, June 2010